Accessibility links
When To Consider Another COVID-19 Booster : Short Wave This week, U.S. Food and Drug Administration vaccine advisors will meet to discuss long-term COVID vaccine strategy. This follows the recent FDA authorization and CDC recommendation of a second booster available for people 50 and older and some immunocompromised people. Going forward, will the strategy change from counting boosters to making a COVID vaccine a seasonal shot? Allison Aubrey talks to Emily Kwong about the latest on boosters, what's known about the vaccination timeline for younger children, and what some experts are saying about the BA.2 variant.

Short Wave

When To Consider Another COVID-19 Booster

When To Consider Another COVID-19 Booster

Listen · 10:30
  • Download
  • <iframe src="https://www.npr.org/player/embed/1090944428/1090957374" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Enlarge this image

US President Joe Biden receives a second booster shot of the Pfizer Covid-19 vaccine a day after the US authorized a fourth dose of either the Pfizer-BioNTech or Moderna Covid-19 vaccines for people 50 and older NICHOLAS KAMM / AFP via Getty Images hide caption

toggle caption
NICHOLAS KAMM / AFP via Getty Images

US President Joe Biden receives a second booster shot of the Pfizer Covid-19 vaccine a day after the US authorized a fourth dose of either the Pfizer-BioNTech or Moderna Covid-19 vaccines for people 50 and older

NICHOLAS KAMM / AFP via Getty Images

This week, U.S. Food and Drug Administration vaccine advisors will meet to discuss long-term COVID vaccine strategy. This follows the recent FDA authorization and CDC recommendation of a second booster available for people 50 and older and some immunocompromised people. Going forward, will the strategy change from counting boosters to making a COVID vaccine a seasonal shot? Allison Aubrey talks to Emily Kwong about the latest on boosters, what's known about the vaccination timeline for younger children, and what some experts are saying about the BA.2 variant.

This story was edited by Gisele Grayson and Carrie Feibel, fact-checked by Gisele and Katherine Sypher and produced by Berly McCoy.